The Effectiveness of Plecanatide for Treating Constipation and Bloating in Patients Aged 18 to 40 Years With Irritable Bowel Syndrome: Utilization of a New Composite Trisymptom Endpoint

By afschroeder • November 11, 2025

Brenner DM, Shin AS, Laitman AP, Deutsch JK, Kunkel DC. The Effectiveness of Plecanatide for Treating Constipation and Bloating in Patients Aged 18 to 40 Years With Irritable Bowel Syndrome: Utilization of a New Composite Trisymptom Endpoint. J Gastroenterol Hepatol. 2025 Nov 10. doi: 10.1111/jgh.70119. Epub ahead of print. PMID: 41214272.

Tags: abdominal pain, bloating, constipation, Digestive Diseases, guanylate cyclase C agonists, Irritable Bowel Syndrome, Publications

Related Posts

Radiology considerations for the PREMIUM study: a multicenter randomized controlled trial of abbreviated MRI versus ultrasound for liver cancer screening in cirrhosis

Dunn DP, Dani G, Sharma A, Ioannou GN, Taddei TH, Chang ST, Onyiuke IY, Planeta BM, Huang GD, Weiss NS, Morgan TR, Dominitz JA, Abou-Alfa[...]

Effect of Age and Age-Defined Menopausal Status on Linaclotide Efficacy and Safety in Adults With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation: Post Hoc Analyses of Phase 2b/3 Studies

Chang L, Staller K, Houghton LA, Yerneni N, Higgins S, Chen W, Wu J, Ford AC, Feuerstadt P, Brenner DM. Effect of Age and Age-Defined[...]

Psychotherapy vs antidepressants in heart failure: Impact of adherence

IsHak WW, Hamilton MA, Diniz MA, Mirocha J, Chernoff R, Hedrick R, Aronow H, Darwish T, Messineo G, Pasini M, Olanisa L, Tetrault E, Arun[...]